Precision Therapeutics, Formerly Skyline Medical, Announces Stock Ticker Symbol Change to AIPT Biotech Investing
Adamas Announces Publication of ADS-5102 Phase 2 Clinical Trial Results in Multiple Sclerosis Journal Pharmaceutical Investing
Gemphire Announces Initiation of Phase 2a Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease Biotech Investing
Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas Biotech Investing
Zogenix Completes Enrollment in Second ZX008 Phase 3 Clinical Trial in Dravet Syndrome Pharmaceutical Investing
AIT Therapeutics Announces Completion of the Agreement to License the Revolutionary Nitric Oxide Generator and Delivery System Pharmaceutical Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
